On June 27, 2025, USANA Health Sciences Inc. signed a new credit agreement allowing up to $75 million in revolving loans, with potential to increase by $200 million, secured by subsidiary stock. The agreement includes financial covenants requiring specific EBITDA levels, which need to be maintained quarterly.